Network origin in Samuel Aparicio first degree
Entity | Entity type | Industry | |
---|---|---|---|
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK.
6
| Extinct | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Samuel Aparicio via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SAREUM HOLDINGS PLC | Miscellaneous | Director/Board Member | |
FUSION IP PLC | Miscellaneous Commercial Services | Director/Board Member | |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Chairman | |
EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chairman | |
FEEDBACK PLC | Packaged Software | Chairman | |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Chairman | |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
Ionix Pharmaceuticals Ltd.
Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree | |
Cambridge Drug Discovery Holdings Ltd.
Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne. | Miscellaneous Commercial Services | Founder | |
Avantium Technologies BV
Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Miscellaneous Commercial Services | Director/Board Member | |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
ABLYNX | Biotechnology | Chief Executive Officer | |
CXR Biosciences Ltd.
CXR Biosciences Ltd. Pharmaceuticals: MajorHealth Technology CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
University of Aston | College/University | Doctorate Degree | |
ProPharma Ltd.
ProPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, ProPharma Ltd. engages in pharmaceutical research and manufactures clinical trial supplies. The company is based in Glasgow, UK. ProPharma was acquired by Evotec SE from University of Strathclyde on October 25, 2005. | Miscellaneous Commercial Services | Director/Board Member | |
Takeda Cambridge Ltd.
Takeda Cambridge Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Cambridge Ltd. is a company that develops and manufactures pharmaceutical products. The company is based in Cambridge, UK and was founded in 1998. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prolysis Ltd.
Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK. | Pharmaceuticals: Major | Director/Board Member | |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Drugstore Chains | Director/Board Member | |
Biofocus, Inc.
Biofocus, Inc. Pharmaceuticals: MajorHealth Technology Biofocus, Inc. operates as a clinical biotechnology company. The company is headquartered in the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Director/Board Member | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
ENTERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Skyline Vet Pharma, Inc.
Skyline Vet Pharma, Inc. Pharmaceuticals: MajorHealth Technology Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT. | Pharmaceuticals: Major | Director/Board Member | |
Procure Therapeutics Ltd. | Chairman | ||
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Founder | |
Nemesis Biosciences Ltd.
Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
NUFORMIX PLC | Biotechnology | Chairman | |
University of Birmingham School | College/University | Graduate Degree | |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | Medical/Nursing Services | Chairman | |
SMALL PHARMA INC. | Drugstore Chains | Chief Operating Officer | |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman |
Statistics
International
United Kingdom | 38 |
United States | 5 |
Belgium | 4 |
Netherlands | 3 |
Germany | 2 |
Sectoral
Health Technology | 25 |
Commercial Services | 11 |
Consumer Services | 4 |
Technology Services | 3 |
Finance | 3 |
Operational
Chairman | 30 |
Director/Board Member | 25 |
Corporate Officer/Principal | 8 |
Chief Executive Officer | 6 |
Doctorate Degree | 3 |
Most connected contacts
Insiders | |
---|---|
Edwin Moses | 35 |
Alastair Riddell | 24 |
Barry Kenny | 8 |
Mark Carlton | 3 |
Jim Sutcliffe | 1 |
Alan Munro | 1 |
- Stock Market
- Insiders
- Samuel Aparicio
- Company connections